The Latest Breaking News from Abbott

The S&P 500 index’s 2024 rally continued in June as solid corporate earnings outweighed concerns over slower economic growth and a potential delay in the Fed’s pivot to interest rate cuts. Further, several Wall Street strategists raised their year-end S&P 500 price targets. Hence, top-performing S&P 500 stocks Amazon.com (AMZN),…

The U.S. Food and Drug Administration took 15 months to act on a whistleblower complaint about the Abbott Nutrition factory at the center 2022's nationwide infant formula shortage

Sprucing up your backyard for summer can be an expensive endeavor, but not with these deals

Here's everything you need to know about what to shop and how to save in the Pottery Barn sales, according to our expert team of eCommerce Editors

The Young and the Restless’ Billy continues to stir the pot at Chancellor-Winters. Will his antics push Devon to work with an unlikely partner?

The stock market suffered significant losses for the week, with ASML and Taiwan Semiconductor slamming the chip sector. Tesla was a big loser.

Abbott Laboratories surpasses profit expectations with strong medical device sales, showcasing market leadership and growth strategies.

Abbott Laboratories came in Wednesday with a "solid" first-quarter report that included a guidance raise, but Abbott stock slipped.

Metabolic health is all the rage, helped by the advent of weight-loss drugs and continuous glucose monitors. Can they change disease forever?